19. Jing Luo, PhD
Targeting Mitochondrial Complex I to enhance PARP inhibition Efficacy in Prostate Cancer Therapy
Targeting Mitochondrial Complex I to enhance PARP inhibition Efficacy in Prostate Cancer Therapy
Acute BRCAness Induction and AR Signaling Blockage through CDK12/7/9 Degradation Enhances PARP Inhibitor Sensitivity in Prostate Cancer
Eliciting anti-tumor immunity in glioblastoma with a bioengineered neoantigen vaccine and nectin family checkpoint blockade therapy
Sodium-glucose Cotransporter-2 Inhibitors For Type 2 Diabetes Mellitus And Lower Risk of Gastrointestinal Cancers
Ferroptosis Suppressor Protein 1 (FSP1) is a Potent and Targetable Inhibitor of Ferroptosis in Chromophobe Renal Cell Carcinoma
EZH2 inhibitors dramatically sensitize breast cancers to HER2 kinase inhibitors through cooperative effects on YAP and pro-apoptotic regulators
Targeted-theranostic nanoparticles induce anti-tumor immune response in lung cancer
Development of gene therapy for pulmonary neoplasm
Dependency of Chromophobe Renal Cell Carcinoma on BCL-xL and MCL-1 for survival
